A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
Authors
Bridgewater, JLopes, A
Beare, S
Duggan, M
Lee, D
Ricamara, M
McEntee, D
Sukumaran, A
Wasan, H
Valle, Juan W
Affiliation
UCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UK.Issue Date
2016-02-24
Metadata
Show full item recordCitation
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study 2016, 16 (1):153 BMC CancerJournal
BMC CancerDOI
10.1186/s12885-016-2174-8Additional Links
http://www.biomedcentral.com/1471-2407/16/153Type
ArticleLanguage
enISSN
1471-2407ae974a485f413a2113503eed53cd6c53
10.1186/s12885-016-2174-8